Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$103.20
-0.6%
$109.51
$77.56
$116.04
$25.10B0.682.26 million shs1.40 million shs
McKesson Co. stock logo
MCK
McKesson
$543.37
+0.6%
$528.15
$352.34
$544.81
$71.40B0.45686,507 shs654,667 shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$360.43
-2.1%
$377.63
$310.42
$415.73
$26.39B1.04516,190 shs599,788 shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
+0.27%-2.07%-7.00%-1.79%+29.13%
McKesson Co. stock logo
MCK
McKesson
+0.82%+4.07%+0.72%+11.31%+50.30%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
-4.55%-2.43%-5.16%+1.89%+3.07%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
4.3567 of 5 stars
1.34.03.33.61.71.73.1
McKesson Co. stock logo
MCK
McKesson
4.8551 of 5 stars
2.45.03.33.03.12.52.5
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
4.8423 of 5 stars
2.45.01.73.23.22.53.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.55
Moderate Buy$103.07-0.12% Downside
McKesson Co. stock logo
MCK
McKesson
2.83
Moderate Buy$533.50-1.82% Downside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.80
Moderate Buy$435.2020.74% Upside

Current Analyst Ratings

Latest CAH, MCK, and WST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
McKesson Co. stock logo
MCK
McKesson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$522.00 ➝ $548.00
4/10/2024
McKesson Co. stock logo
MCK
McKesson
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$510.00 ➝ $570.00
3/6/2024
McKesson Co. stock logo
MCK
McKesson
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$575.00 ➝ $620.00
2/26/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/26/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$125.00
2/26/2024
McKesson Co. stock logo
MCK
McKesson
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
2/26/2024
McKesson Co. stock logo
MCK
McKesson
SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$600.00
2/16/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$400.00 ➝ $375.00
2/13/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$440.00 ➝ $470.00
2/9/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
2/9/2024
McKesson Co. stock logo
MCK
McKesson
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$450.00 ➝ $505.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$205.01B0.12$8.66 per share11.92($11.20) per share-9.21
McKesson Co. stock logo
MCK
McKesson
$276.71B0.26$32.69 per share16.62($10.99) per share-49.44
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.95B8.95$9.51 per share37.90$39.31 per share9.17

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$261M$2.5440.6312.961.000.30%-57.44%3.89%5/2/2024 (Confirmed)
McKesson Co. stock logo
MCK
McKesson
$3.56B$22.0724.6217.491.420.99%-262.63%5.96%5/7/2024 (Confirmed)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$593.40M$7.8845.7439.526.5920.12%21.60%16.26%7/25/2024 (Estimated)

Latest CAH, MCK, and WST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
McKesson Co. stock logo
MCK
McKesson
$6.39N/A-$6.39N/AN/AN/A  
5/2/2024N/A
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.96N/A-$1.96N/AN/AN/A  
4/25/2024Q1 2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.29$1.56+$0.27$1.57$670.62 million$695.40 million    
2/15/202412/31/2023
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.78$1.83+$0.05$1.83$740.43 million$732.00 million      
2/7/2024Q3 2024
McKesson Co. stock logo
MCK
McKesson
$7.05$7.74+$0.69$11.06$77.93 billion$80.90 billion    
2/1/2024Q2 2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.56$1.82+$0.26$2.21$57.02 billion$57.45 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.001.94%+1.00%78.74%27 Years
McKesson Co. stock logo
MCK
McKesson
$2.480.46%+11.80%11.24%16 Years
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.800.22%+5.81%10.15%1 Years

Latest CAH, MCK, and WST Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/25/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Quarterly$0.200.22%7/31/20247/31/20248/7/2024
4/24/2024
McKesson Co. stock logo
MCK
McKesson
quarterly$0.620.47%5/31/20246/3/20247/1/2024
2/20/2024
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Quarterly$0.200.23%4/23/20244/24/20245/1/2024
2/6/2024
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.50061.92%3/28/20244/1/20244/15/2024
2/1/2024
McKesson Co. stock logo
MCK
McKesson
quarterly$0.620.5%2/29/20243/1/20244/1/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
0.98
0.50
McKesson Co. stock logo
MCK
McKesson
N/A
0.92
0.50
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.03
2.88
2.24

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
McKesson Co. stock logo
MCK
McKesson
85.07%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.15%
McKesson Co. stock logo
MCK
McKesson
0.21%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.53%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
48,000243.23 million242.87 millionOptionable
McKesson Co. stock logo
MCK
McKesson
51,000131.41 million131.13 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,60073.21 million72.82 millionOptionable

CAH, MCK, and WST Headlines

SourceHeadline
Stevens Capital Management LP Purchases New Stake in West Pharmaceutical Services, Inc. (NYSE:WST)Stevens Capital Management LP Purchases New Stake in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 26 at 5:57 PM
West Pharmaceutical Services: Strong Q1 Performance and Upbeat FY24 Outlook Bolster Buy RatingWest Pharmaceutical Services: Strong Q1 Performance and Upbeat FY24 Outlook Bolster Buy Rating
markets.businessinsider.com - April 26 at 2:59 PM
West Pharmaceutical Services (NYSE:WST) Releases Quarterly  Earnings Results, Beats Expectations By $0.27 EPSWest Pharmaceutical Services (NYSE:WST) Releases Quarterly Earnings Results, Beats Expectations By $0.27 EPS
marketbeat.com - April 26 at 11:48 AM
West Pharmaceutical Services First Quarter 2024 Earnings: Beats ExpectationsWest Pharmaceutical Services First Quarter 2024 Earnings: Beats Expectations
finance.yahoo.com - April 26 at 9:58 AM
West Pharmaceutical Services, Inc. Declares Quarterly Dividend of $0.20 (NYSE:WST)West Pharmaceutical Services, Inc. Declares Quarterly Dividend of $0.20 (NYSE:WST)
marketbeat.com - April 26 at 8:00 AM
West Pharmaceutical Services Inc (WST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...West Pharmaceutical Services Inc (WST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
finance.yahoo.com - April 26 at 4:58 AM
Beyond The Earnings: What The Latest SEC 10-Q Filing Reveals About West Pharmaceutical Services, Inc. (WST) FutureBeyond The Earnings: What The Latest SEC 10-Q Filing Reveals About West Pharmaceutical Services, Inc. (WST) Future
americanbankingnews.com - April 26 at 4:06 AM
West Pharmaceutical Services, Inc. 2024 Q1 - Results - Earnings Call PresentationWest Pharmaceutical Services, Inc. 2024 Q1 - Results - Earnings Call Presentation
seekingalpha.com - April 25 at 5:43 PM
West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales WeakWest Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak
zacks.com - April 25 at 11:35 AM
West Pharmaceutical Services, Inc.: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 DividendWest Pharmaceutical Services, Inc.: West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
finanznachrichten.de - April 25 at 8:55 AM
West Pharmaceutical: Q1 Earnings SnapshotWest Pharmaceutical: Q1 Earnings Snapshot
timesunion.com - April 25 at 8:55 AM
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Illinois Municipal Retirement FundWest Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Illinois Municipal Retirement Fund
marketbeat.com - April 25 at 8:30 AM
West Pharmaceutical Services Inc. (WST) Q1 2024 Earnings: Adjusted EPS Rises Amidst Sales DeclineWest Pharmaceutical Services Inc. (WST) Q1 2024 Earnings: Adjusted EPS Rises Amidst Sales Decline
gurufocus.com - April 25 at 8:24 AM
West Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue EstimatesWest Pharmaceutical Services (WST) Tops Q1 Earnings and Revenue Estimates
zacks.com - April 25 at 8:11 AM
West Pharmaceutical Services (NYSE:WST) Releases FY 2024 Earnings GuidanceWest Pharmaceutical Services (NYSE:WST) Releases FY 2024 Earnings Guidance
marketbeat.com - April 25 at 7:39 AM
West Pharma posts beat-and-raise quarter aided by strong demand for injectablesWest Pharma posts beat-and-raise quarter aided by strong demand for injectables
reuters.com - April 25 at 7:11 AM
West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 DividendWest Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend
prnewswire.com - April 25 at 6:00 AM
Will West Pharmaceutical (WST) Beat Estimates Again in Its Next Earnings Report?Will West Pharmaceutical (WST) Beat Estimates Again in Its Next Earnings Report?
zacks.com - April 24 at 1:16 PM
Handelsbanken Fonder AB Lowers Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)Handelsbanken Fonder AB Lowers Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 24 at 6:48 AM
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Mackenzie Financial CorpWest Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Mackenzie Financial Corp
marketbeat.com - April 23 at 5:11 AM
Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
zacks.com - April 22 at 10:46 AM
West Pharmaceutical Services, Inc. Plans Quarterly Dividend of $0.20 (NYSE:WST)West Pharmaceutical Services, Inc. Plans Quarterly Dividend of $0.20 (NYSE:WST)
americanbankingnews.com - April 22 at 8:28 AM
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Purchased by abrdn plcWest Pharmaceutical Services, Inc. (NYSE:WST) Shares Purchased by abrdn plc
marketbeat.com - April 22 at 7:20 AM
Ardevora Asset Management LLP Sells 11,511 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)Ardevora Asset Management LLP Sells 11,511 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)
marketbeat.com - April 21 at 9:25 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Cardinal Health logo

Cardinal Health

NYSE:CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
McKesson logo

McKesson

NYSE:MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
West Pharmaceutical Services logo

West Pharmaceutical Services

NYSE:WST
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.